InvestorsHub Logo
Followers 9
Posts 567
Boards Moderated 0
Alias Born 02/07/2020

Re: HyGro post# 203452

Tuesday, 02/15/2022 11:50:42 PM

Tuesday, February 15, 2022 11:50:42 PM

Post# of 232582
Ok, let’s say EVERYTHING in your last paragraph is true!! Was that talk about LL from CEO going to somehow get the drug approved?? NO WAY!! IT FAILED THE TRIAL!! Should the SEC/DOJ be hot on the trail!! Sure if NADER is guilty!! Where the strange part occurs is the FDA feeling threatened by that PR and the need to respond. WHY?? A CEO points out data within a trial (right or wrong) and the FDA feels it’s necessary to respond?? What is the threat?? The drug failed the trial!! Not going to be granted EUA!! They say they wrote the “hit piece” due to “significant public interest”? BS!! Seriously, how many people knew about LL?? How many people follow a small start up Biotech company on the OTC? How many people read PR’s from a start up Biotech company on the OTC??? NOT MANY!! So even the reason for the “hit piece” is suspicious at best... In my opinion which cannot be proved at this time, the only reason to set up a failure in CD12 and to write a “hit piece” letter right before things were getting rolling in the Philippines was to kill this drug. So why kill the drug?? Easy, FDA wanted to push vaccines and a viable therapeutic would get in the way. Been saying this quite a bit and low and behold someone posted a video from project veritas with a former FDA higher up talking about vaccines!! Hmmmmmmmmm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News